NXGN - NextGen Healthcare Non-GAAP EPS of $0.16 in-line revenue of $153.3M in-line 2023 revenue outlook below estimates

• NextGen Healthcare press release ( NASDAQ: NXGN ): Q1 Non-GAAP EPS of $0.16 in-line.
• Revenue of $153.3M (+4.9% Y/Y) in-line.
• Outlook for fiscal 2023:
• Revenue is between $621 million and $633 million, from between $628 million and $640 million vs. $633.91M consensus.
• Adjusted EBITDA is between $109 million and $114 million, from between $111 million and $116 million
• Non-GAAP earnings per share is between $0.92 and $0.98, from between $0.95 and $1.01 vs. $0.97 consensus.

For further details see: